Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
092076
Wellcome Trust - United Kingdom
Biotechnology and Biological Sciences Research Council - United Kingdom
Cancer Research UK - United Kingdom
PubMed
25543083
DOI
10.1016/j.jmb.2014.12.011
PII: S0022-2836(14)00645-7
Knihovny.cz E-zdroje
- Klíčová slova
- MDM2, RING domain, allostery, linear motifs, ubiquitination,
- MeSH
- alosterická regulace MeSH
- aminokyselinové motivy MeSH
- bodová mutace * MeSH
- hydrolýza MeSH
- konformace proteinů MeSH
- lidé MeSH
- molekulární sekvence - údaje MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- nádorový supresorový protein p53 chemie metabolismus MeSH
- polyubikvitin metabolismus MeSH
- protoonkogenní proteiny c-mdm2 chemie genetika metabolismus MeSH
- sekvence aminokyselin MeSH
- terciární struktura proteinů MeSH
- ubikvitin konjugující enzymy metabolismus MeSH
- ubikvitin metabolismus MeSH
- ubikvitinace MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- nádorový supresorový protein p53 MeSH
- polyubikvitin MeSH
- protoonkogenní proteiny c-mdm2 MeSH
- UBE2D1 protein, human MeSH Prohlížeč
- ubikvitin konjugující enzymy MeSH
- ubikvitin MeSH
Mouse double minute 2 (MDM2) has a phosphorylation site within a lid motif at Ser17 whose phosphomimetic mutation to Asp17 stimulates MDM2-mediated polyubiquitination of p53. MDM2 lid deletion, but not Asp17 mutation, induced a blue shift in the λ(max) of intrinsic fluorescence derived from residues in the central domain including Trp235, Trp303, Trp323, and Trp329. This indicates that the Asp17 mutation does not alter the conformation of MDM2 surrounding the tryptophan residues. In addition, Phe235 mutation enhanced MDM2 binding to p53 but did not stimulate its ubiquitination function, thus uncoupling increases in p53 binding from its E3 ubiquitin ligase function. However, the Asp17 mutation in MDM2 stimulated its discharge of the UBCH5a-ubiquitin thioester adduct (UBCH5a is a ubiquitin-conjugating enzyme E2D 1 UBC4/5 homolog yeast). This stimulation of ubiquitin discharge from E2 was independent of the p53 substrate. There are now four known effects of the Asp17 mutation on MDM2: (i) it alters the conformation of the isolated N-terminus as defined by NMR; (ii) it induces increased thermostability of the isolated N-terminal domain; (iii) it stimulates the allosteric interaction of MDM2 with the DNA-binding domain of p53; and (iv) it stimulates a novel protein-protein interaction with the E2-ubiquitin complex in the absence of substrate p53 that, in turn, increases hydrolysis of the E2-ubiquitin thioester bond. These data also suggest a new strategy to disrupt MDM2 function by targeting the E2-ubiquitin discharge reaction.
Edinburgh Centre for Chemical Biology University of Edinburgh Edinburgh EH8 9YL United Kingdom
RECAMO Masaryk Memorial Cancer Institute 656 53 Brno Czech Republic
Citace poskytuje Crossref.org
Allosteric changes in HDM2 by the ATM phosphomimetic S395D mutation: implications on HDM2 function